cache/ee1256fd1777f1bc4cb02cf6117100c9a1c87d3677ad7bd4d3a2525e1de21731

COM:CASPIANCHEMICAL

Caspian Chemical

  • Privately Held

Company Overview

Metric
Company NameCaspian ChemicalEvonik Industries AG
SymbolEVK
MSH IDCOM:CASPIANCHEMICALCOM:EVONIK:CORPORATE
MarketPRIVATESTOCKS
SectorBasic Materials & MaterialsBasic Materials
IndustryChemicalsChemicals - Specialty
CountryAEDE
Stage
Employee Count33.09K
Websitecaspianchemical.comcorporate.evonik.com/en
LinkedInevonik
Founders

Market Metrics

Metric
Market Cap9.28B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Financial Performance

Metric
Revenue16.13B
Revenue (LTM)
Revenue (NTM)
Gross Profit2.85B
EBITDA1.13B
Operating Income-31.69M
Net Income-491.15M
EPS-1.06
Diluted EPS-1.06
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.22
Operating Profit Margin0.05
EBITDA Margin0.07
Net Profit Margin-0.01
Return on Equity-0.01
Return on Assets-0.00
Return on Capital Employed0.04

Valuation Multiples

Metric
P/E Ratio-13.29
P/B Ratio0.79
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio0.65
EV Multiple3.41

Operational Metrics

Metric
Days Sales Outstanding50.27
Days Payables Outstanding41.85
Days Inventory Outstanding81.00
Operating Cycle129.14
Cash Conversion Cycle76.72
Asset Turnover0.75

Cash Flow Metrics

Metric
Operating Cash Flow1.61B
Free Cash Flow775.27M
Cash Flow to Debt0.46
Operating Cash Flow/Sales0.14
Free Cash Flow Yield0.11

Balance Sheet Metrics

Metric
Cash & Equivalents791.12M
Accounts Receivable110.90M
Inventory2.48B
Goodwill4.84B
Debt to Capitalization0.35
Debt to Assets
Current Ratio1.45
Quick Ratio0.88

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue0.03
SG&A to Revenue0.03